Catheters Market Outlook, 2030

The global catheter market has undergone a remarkable transformation, evolving from simple drainage tubes to highly specialized devices critical in modern medicine, such as cardiovascular, urological, neurovascular, and intravenous applications. For example, in cardiac procedures, balloon and stent catheters enable minimally invasive interventions that reduce hospital stays and improve recovery times, while in urology, Foley catheters are indispensable for managing urinary retention and post-surgical care. The market’s growth is largely driven by the rising incidence of chronic conditions like heart disease, diabetes, and neurological disorders, which increase the need for surgical interventions and continuous patient monitoring.

Technological innovation has been a key factor, with developments such as antimicrobial-coated catheters reducing infection risks, bioresorbable materials minimizing tissue damage, and sensor-enabled “smart” catheters allowing real-time monitoring of blood flow or intracranial pressure, enhancing both patient safety and procedural precision. Companies actively promote these advancements through medical conferences, workshops, and digital campaigns targeting healthcare professionals, emphasizing how these products improve clinical outcomes and operational efficiency. Regulatory frameworks play a central role in shaping the market; for instance, the U.S.

FDA and the European Medicines Agency strictly monitor device approval, requiring rigorous testing and quality standards, while certifications like ISO 13485 assure hospitals of device reliability. For instance, the study published by the Lancet in May 2024 reports that urinary tract infections (UTIs) affect approximately 250 million people annually worldwide. With the increasing prevalence of such urological conditions, the demand for catheterization for short-term or long-term management of these ailments is anticipated to increase in the coming years, propelling market growth over the forecast period.

According to the research report “Global Catheters Market Outlook, 2030”, the Global Catheters market is projected to reach market size of USD 77.73 Billion by 2030 increasing from USD 51.40 Billion in 2024, growing with 7.29% CAGR by 2025-30. The increasing prevalence of surgical and diagnostic procedures across specialties such as cardiology, urology, and interventional radiology, which rely heavily on catheters for precision and efficiency. For example, neurovascular catheters are now routinely used in treating strokes and aneurysms, offering life-saving minimally invasive alternatives to traditional surgery.

Rising healthcare awareness and patient preference for outpatient and day-care procedures also boost catheter adoption, as these devices enable faster recovery and lower hospitalization costs. For instance, in February 2024, Junkosha, a materials specialist company, launched the 1.8: 1 shrink ratio Translucent PHST solution, which aids catheter manufacturers.

This product allows for the easy addition of complex shapes and designs to the catheter, streamlining the manufacturing process and boosting efficiency. Moreover, integration of data-driven innovations, such as catheter-based sensors linked to electronic health records, allows clinicians to track patient metrics in real-time, driving interest from hospitals and research institutions.

With an increasing emphasis on preventing catheter-associated infections like CAUTI and CLABSIs, manufacturers have a significant opportunity to enhance their market position by introducing innovative antimicrobial catheters. For instance, in November 2023, CorMedix Inc. received FDA approval for its DefenCath catheter. It was designed to reduce catheter-related bloodstream infections in a limited population of adult patients with kidney failure undergoing chronic hemodialysis via a central venous catheter (CVC).

Key supporting events, such as international medical device expos, cardiology symposia, and urology workshops, provide platforms to showcase the latest catheter innovations, educate practitioners, and encourage cross-industry collaborations. Healthcare professionals prefer the use of catheters that pose minimal infection risks due to their increased awareness and emphasis on infection control. For instance, in May 2023, BD introduced a convenient prefilled flush syringe for customers. This innovative BD PosiFlush SafeScrub syringe is designed to enhance patient care by expediting the flushing and disinfection of IV catheters during clinical procedures.

Market Drivers

• Rising Prevalence of Chronic Diseases: The growing number of patients suffering from cardiovascular diseases, diabetes, and kidney disorders is significantly increasing the demand for catheter-based procedures. As these chronic conditions often require continuous monitoring, interventions, or surgeries, hospitals and clinics are increasingly relying on catheters for effective patient care.
• Preference for Minimally Invasive Procedures: Patients and healthcare providers are favoring minimally invasive surgeries due to shorter recovery times, reduced risk of complications, and lower overall costs. Catheters play a central role in these procedures, whether in cardiovascular, urinary, or vascular interventions, which is driving their widespread adoption across medical facilities.

Market Challenges

• Risk of Infections: Despite technological advancements, catheter-associated infections remain a significant challenge for both patients and healthcare providers. Urinary tract infections, bloodstream infections, and other complications linked to catheter use increase patient morbidity and extend hospital stays. Manufacturers must continuously invest in designing catheters with antimicrobial coatings, improved materials, or single-use designs to mitigate infection risks, but balancing safety with cost-effectiveness remains a persistent challenge.
• High Cost of Advanced Catheters: Specialized catheters, such as those used for MRI-compatible procedures or complex cardiovascular interventions, involve significant production and research costs. This high pricing restricts their availability in emerging and cost-sensitive markets, limiting market penetration. Moreover, the need for specialized training to operate advanced catheters can further increase costs for healthcare facilities, slowing adoption in regions where medical infrastructure is still developing.

Market Trends

• Integration of Smart Technologies: The development of smart catheters equipped with sensors, microchips, and connectivity features is transforming the market. These catheters can monitor vital parameters such as blood pressure, flow rates, and chemical markers in real time, providing clinicians with instant feedback during procedures. Such innovation not only enhances procedural accuracy but also enables personalized treatment planning, reducing risks and improving outcomes for patients with complex conditions.
• Expansion into Emerging Markets: The increasing healthcare expenditure and improving infrastructure in emerging regions, particularly in Asia-Pacific and Latin America, are creating new growth opportunities for catheter manufacturers. Companies are targeting these markets to provide affordable yet high-quality catheters, often through partnerships with local distributors. This trend not only drives revenue growth but also addresses previously unmet medical needs in regions with rising chronic disease prevalence and growing patient populations.Cardiovascular catheters lead the global catheters market due to the rising prevalence of cardiovascular diseases (CVDs) worldwide, coupled with increasing adoption of minimally invasive diagnostic and therapeutic procedures.

The dominance of cardiovascular catheters in the global catheters market can be attributed primarily to the unprecedented rise in cardiovascular diseases, which are now the leading cause of mortality globally. Conditions such as coronary artery disease, arrhythmias, valvular heart diseases, and peripheral vascular disorders have created a significant demand for precise diagnostic and interventional tools. Cardiovascular catheters, being versatile and essential for procedures like angiography, angioplasty, stenting, and electrophysiological mapping, have become indispensable in modern cardiology.

Their ability to provide minimally invasive solutions reduces patient recovery time, lowers hospital stays, and minimizes the risks associated with open-heart surgeries, making them highly preferred by both healthcare providers and patients. Technological advancements in catheter design, including the development of drug-eluting catheters, shape-memory materials, hydrophilic coatings, and improved biocompatibility, have further strengthened their market position. These innovations enhance procedural accuracy, reduce complications such as thrombosis or vessel trauma, and improve overall patient outcomes, fueling adoption in both developed and emerging markets.

Additionally, the growing geriatric population, which is more susceptible to cardiovascular ailments, directly contributes to the rising demand for cardiovascular catheters. Hospitals, ambulatory surgical centers, and specialized cardiology clinics increasingly rely on these catheters to manage complex cardiovascular conditions efficiently, leading to higher procurement rates. Preventive healthcare initiatives, rising health awareness, and regular screening programs have also driven early diagnosis of heart-related disorders, further boosting catheter usage.

Single-lumen catheters lead the global catheters market due to their simplicity, versatility, and widespread applicability in a broad range of clinical procedures, making them a preferred choice for healthcare providers.

The prominence of single-lumen catheters in the global catheters market is driven by their fundamental design, which combines simplicity with high clinical utility, allowing them to be used across numerous medical applications. Unlike multi-lumen catheters that are designed for specialized purposes, single-lumen catheters are easy to manufacture, cost-effective, and highly adaptable for procedures such as urinary drainage, intravenous therapy, diagnostic sampling, and basic fluid administration. Their streamlined design reduces the risk of complications like infections or mechanical failures, which is critical in both inpatient and outpatient settings.

Clinicians often prefer single-lumen catheters for routine procedures because they are straightforward to insert, require minimal training for effective use, and can be deployed rapidly in emergency situations. Additionally, the lower cost compared to multi-lumen alternatives makes single-lumen catheters highly attractive for hospitals and healthcare facilities in both developed and emerging markets, where budget constraints and cost-effective care are significant considerations. The widespread adoption of minimally invasive techniques and outpatient procedures further enhances the demand for single-lumen catheters, as these procedures often require precise yet uncomplicated access to veins, arteries, or urinary pathways.

Advances in material science have also contributed to their market leadership; modern single-lumen catheters are constructed from biocompatible polymers that reduce the risk of irritation, thrombosis, or infections, improving patient safety and procedural efficiency. The availability of a wide range of sizes, lengths, and tip configurations allows single-lumen catheters to be tailored to specific patient needs, enhancing versatility and clinical outcomes.

Hospital stores lead the global catheters distribution channel due to their direct access to end-users, ability to ensure timely availability of products, and integration within hospital supply chains, making them the most efficient channel for catheter distribution.

The dominance of hospital stores as a distribution channel in the global catheters market stems from their strategic position within healthcare institutions, which allows them to provide direct and reliable access to critical medical devices, including catheters. Hospitals are among the largest consumers of catheters due to the high frequency of procedures such as surgeries, diagnostic interventions, intravenous therapy, and urinary management. By maintaining in-house stores, hospitals can effectively manage inventory, monitor usage, and ensure immediate availability of various catheter types, including single-lumen, multi-lumen, and cardiovascular catheters.

This internal distribution system reduces dependency on external suppliers, minimizes supply chain disruptions, and ensures that clinicians and nursing staff have the necessary tools at the point of care. Furthermore, hospital stores offer the advantage of streamlined procurement and bulk purchasing, allowing healthcare facilities to negotiate better pricing with manufacturers, which is particularly important given the recurring need for disposable catheter products. The integration of hospital stores with hospital management systems and electronic health records enhances the efficiency of inventory tracking and replenishment, reducing wastage and preventing stockouts.

This level of control is difficult to achieve through external distributors or third-party retail channels, which may face delays or logistical challenges in meeting urgent demand. Additionally, hospital stores can provide targeted training and support for healthcare personnel, ensuring that catheters are used correctly and safely, which is critical for reducing complications and improving patient outcomes. The rising complexity of medical procedures and the increasing adoption of minimally invasive techniques have further emphasized the importance of ready access to specialized catheters, making hospital stores the preferred distribution route.

Hospitals and Ambulatory Surgical Centers (ASCs) lead as the primary end-users in the global catheters market due to their high procedural volume, advanced infrastructure, and constant demand for a wide range of catheter types for both diagnostic and therapeutic interventions.

The leading position of hospitals and ambulatory surgical centers (ASCs) as end-users in the global catheters market is primarily driven by their central role in delivering critical and routine medical care that requires the use of catheters. Hospitals, including general, specialty, and tertiary care facilities, are hubs for a wide array of procedures such as cardiovascular interventions, urological treatments, intravenous therapy, and diagnostic imaging, all of which rely heavily on catheters. Their high patient volume and the complexity of procedures performed make them consistent and significant consumers of catheter products, ranging from single-lumen and multi-lumen catheters to highly specialized cardiovascular devices.

Ambulatory Surgical Centers, which provide same-day surgical services, have grown in prominence due to the global shift toward minimally invasive and cost-effective outpatient care, further expanding the demand for catheters in non-hospital settings. ASCs are preferred by patients for elective surgeries because they offer reduced waiting times, lower costs, and shorter recovery periods compared to traditional hospital stays, and these advantages increase the frequency of catheter use for procedures like cardiac catheterization, urological surgeries, and endovascular interventions.

The adoption of advanced technologies and minimally invasive procedures in both hospitals and ASCs also fuels catheter consumption, as these interventions rely on precision devices to reduce patient risk, improve outcomes, and shorten recovery times. Additionally, hospitals and ASCs maintain structured supply chains and internal inventory systems, ensuring the availability of various catheter types when needed, which supports uninterrupted procedural efficiency.

The ongoing expansion of healthcare infrastructure worldwide, particularly in emerging economies, has led to an increase in the number of hospitals and ASCs, thereby enlarging the pool of end-users and driving catheter demand.North America leads the global catheters market due to its advanced healthcare infrastructure, high prevalence of chronic and cardiovascular diseases, widespread adoption of minimally invasive procedures, and strong presence of major medical device manufacturers.

The leadership of North America in the global catheters market is primarily driven by a combination of well-established healthcare infrastructure, a technologically advanced medical ecosystem, and a high prevalence of conditions that require catheter-based interventions. The region, particularly the United States, hosts some of the world’s most sophisticated hospitals, ambulatory surgical centers, and specialized cardiac and urology clinics, all of which rely heavily on catheters for diagnostics, treatment, and patient monitoring.

Cardiovascular diseases, chronic kidney disorders, and urological conditions are widespread in North America due to aging populations, sedentary lifestyles, and high rates of comorbidities such as diabetes and hypertension, creating a steady and substantial demand for catheters across multiple healthcare segments. The widespread adoption of minimally invasive procedures in the region further reinforces catheter demand, as such interventions are preferred for their reduced patient recovery times, lower complication rates, and cost-effectiveness compared to traditional surgeries.

North America is also home to leading global medical device manufacturers who continuously innovate and supply a diverse range of catheter products, including single-lumen, multi-lumen, and advanced cardiovascular catheters, which are rigorously tested to meet stringent regulatory standards. The Food and Drug Administration (FDA) ensures high safety and quality benchmarks for catheters, building clinician and patient confidence and supporting widespread usage. Additionally, strong reimbursement frameworks and health insurance coverage facilitate greater access to catheter-based interventions, enabling hospitals and ASCs to perform a higher volume of procedures without imposing prohibitive costs on patients.

• In March 2025, Perfuze, a leading medical device company dedicated to advancing stroke treatment, announced that it had received FDA 510(k) clearance for its Zipline Access Catheters. This regulatory milestone strengthens Perfuze’s growing portfolio of innovative neurovascular devices, empowering physicians to treat acute ischemic strokes with greater speed, ease, and precision.
• In March 2025, Supira Medical announced that the company had raised USD 120 million to complete the clinical development of its temporary heart pump, designed for patients undergoing high-risk cardiac procedures or suffering from shock.
• In January 2025, B. Braun Medical Inc. announced the launch of its new Clik-FIX Epidural/Peripheral Nerve Block (PNB) Catheter Securement Device. This addition to the Clik-FIX family is designed to be soft, low-profile, and secure. It aims to reduce the risk of catheter displacement and dislodgement during regional anesthesia procedures. The device is intended for straightforward application and reliable securement, addressing challenges faced by patients and healthcare professionals.
• In January 2025, Radical Catheter Technologies announced that its 8F Neurovascular Catheter has received 510(k) clearance from the FDA. The 8F catheter is built upon Radical's patented ribbon technology platform, offering an enlarged inner diameter to expand therapeutic options in neurovascular procedures. This design provides flexibility, stability, and durability, potentially leading to quicker procedures with reduced risks and costs.
• In January 2025, Dr. Bruce Gardner, a radiologist at Sanford Health, received U.S. FDA approval for his innovative catheter design to prevent accidental dislodgement injuries. The new catheter features a mechanism that allows the retention balloon to deflate rapidly when excessive tension is applied, thereby minimizing potential patient harm.
• In February 2025, Johnson & Johnson MedTech launched the next-generation CEREGLIDE 92 Catheter System, which features a 0.092” inner diameter. This innovative catheter incorporates several design elements, including the co-packaged INNERGLIDE 9 Delivery Aid, complete catheter visibility through BRITE-LINE Technology, and TruCourse Technology, enhancing distal tip flexibility for improved trackability.
• In December 2024, Terumo Interventional Systems (TIS), a division of Terumo Corporation, announced the U.S. launch of its R2P NaviCross Peripheral Support Catheter, further expanding its radial-to-peripheral (R2P) portfolio. Available in a 200-cm length, the catheter features a double-braided, stainless-steel construction designed to provide superior trackability and torque control, facilitating lesion crossing in complex procedures.